Skip to main content
TipRanks
Go Ultimate75% OFF

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (2591) Income Statement

0 Followers

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Income Statement

Last quarter (Q2 2026), Guangzhou Innogen Pharmaceutical Group Co Ltd Class H's total revenue was ¥77.14M. In Q2, Guangzhou Innogen Pharmaceutical Group Co Ltd Class H's net income was ¥-113.87M. See Guangzhou Innogen Pharmaceutical Group Co Ltd Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22
¥ 128.11M¥ 0.00¥ 0.00¥ 0.00
¥ 104.43M¥ -17.28M¥ -19.65M¥ -19.08M
¥ 438.33M¥ 156.35M¥ 746.84M¥ 308.37M
Depreciation and Amortization¥ 9.98M¥ 16.92M¥ 19.64M¥ 19.08M
¥ -323.92M¥ -156.89M¥ -711.42M¥ -308.37M
¥ -333.90M¥ -189.36M¥ -746.84M¥ -327.45M
¥ 1.37M¥ 14.67M¥ 13.46M¥ 20.46M
¥ -332.53M¥ -174.69M¥ -733.38M¥ -306.99M
¥ -332.53M¥ -174.69M¥ -733.38M¥ -306.99M
Per Share Metrics
Basic EPS¥ -0.76¥ -0.38¥ -1.61¥ -0.68
Diluted EPS¥ -0.76¥ -0.38¥ -1.60¥ -0.68
Weighted Average Shares Outstanding434.08M456.82M456.82M456.82M
Weighted Average Shares Outstanding (Diluted)434.08M456.82M456.82M456.82M

Currency in CNY

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Earnings and Revenue History

-800M-400M0400M-261 %-260 %-259 %-258 %EarningsProfit Margin2022202320242025RevenueEarningsProfit Margin